Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PMVP
SELLPMV Pharmaceuticals, Inc. · Healthcare · United States · $66M · Avg Vol: $354K/d
25
StockRankGet insider-trade alerts
Q
31
V
35
M
47
P/E (TTM)
—
ROE
-63.2%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)+6.3%
SMA 50SMA 200
Close
$1.18
RSI (14)
45.2
52W High
$1.88
From 52W High
0.6%
SCORE BREAKDOWN
Quality
31
ROIC
-79.6%8.6
ROE
-63.2%15.1
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
-63.1%3.7
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.00x90.3
Current Ratio
11.14x88.4
Value
35
P/E (TTM)
—N/A
EV/EBITDA
0.3x25.0
P/FCF
—N/A
P/B
0.8x91.2
P/S
—N/A
Div Yield
—N/A
Momentum
47
52W High %
63%43.4
RS 6M
-7%64.6
SMA 50/200
0.94x51.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+26%38.9
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$66M
P/E (Forward)
-1.1x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PMVP are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc.(you) | $66M | 25 | SELL |
| XBIT | XBiotech Inc. | $69M | 29 | SELL |
| ATRA | Atara Biotherapeutics, Inc. | $71M | 29 | SELL |
| ACET | Adicet Bio, Inc. | $73M | 21 | SELL |
| LONA | LeonaBio, Inc. | $69M | 30 | SELL |
| PTHS | Pelthos Therapeutics Inc. | $90M | 24 | SELL |
| PLRX | Pliant Therapeutics, Inc. | $67M | 18 | STRONG SELL |
| 4875.T | MediciNova, Inc. | $62M | 18 | STRONG SELL |
| OSTX | OS Therapies Incorporated | $68M | 16 | STRONG SELL |
| ACRV | Acrivon Therapeutics, Inc. | $68M | 14 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%